|
    ABVC U.S.: Nasdaq

    ABVC Biopharma Inc.

    ABVCUS
    After Hours
    Last Updated: Sep 17, 2021 6:35 p.m. EDT Delayed quote

    $ 2.8600

    0.00 0.00%
    After Hours Volume: 50.48K
    Close Chg Chg %
    $2.8600 0.2500 9.58%
    Advanced Charting
    Volume: 286.11K 65 Day Avg: 1.49M
    19% vs Avg
    2.5600 Day Range 2.9000
    1.9500 52 Week Range 29.9500

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    ABVC Overview

    Performance

    5 Day
    • -10.90%
    1 Month
    • 40.89%
    3 Month
    • -39.79%
    YTD
    • -43.92%
    1 Year
    • -28.50%

    Company News for Sep 2, 2021

    on Zacks.com

    ABVC Biopharma Inc.

    ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of new drugs and medical devices. The company also integrates research achievements from Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center. It conducts clinical trials of translational medicine for Proof of Concept and out-licenses it to international pharmaceutical companies. Its products include BLI-1005 CNS-Major Depressive Disorder; BLI-1008 CNS-Attention Deficit Hyperactivity Disorder; BLI-1401-1 Anti-Tumor Combination Therapy-Solid Tumor with Anti-PD-1; BLI-1401-2 Anti-Tumor Combination Therapy-Triple Negative Breast Cancer; and BLI-1501 Hematology-Chronic Lymphocytic Leukemia. The company was founded in 1990 and is headquartered in Fremont, CA.